This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of biologically active molecules. It serves as a key intermediate in the creation of potential drug candidates targeting neurological disorders and other therapeutic areas. Its unique structure, combining a fluoropyridine moiety with a hydroxypiperidine group, makes it valuable for designing compounds with specific binding affinities to biological targets. Researchers often employ it in medicinal chemistry to explore its potential in modulating enzyme activity or receptor interactions, contributing to the development of novel treatments.